Added to YB: 2024-08-20
Pitch date: 2024-08-17
CLPT [bullish]
ClearPoint Neuro, Inc.
+17.25%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions.
Market Cap
$438.6M
Pitch Price
$10.84
Price Target
N/A
Dividend
N/A
EV/EBITDA
-20.80
P/E
-18.67
EV/Sales
12.70
Sector
Health Care Equipment and Supplies
Category
growth
ClearPoint Neuro's Strategic Expansion: A Medtech Powerhouse in the Making
CLPT: Biotech ETF wrapped in medtech platform. Q2 shows inflection: 76% stock run, improved margins, reduced burn. On track to exceed 100 sites by 2025. New OR & LITT systems, biologics growth (7 FDA fast-tracked), royalty deals. Underrated: CGMP facility, data moat, strategic pharma partner. Cash flow breakeven expected Q4 2025.
Read full article (3 min)